The House Ethics Committee is reviewing allegations that Rep. Chris Collins (R-NY) “engaged in misconduct, four months after his personal investment practices came under scrutiny in the media,” the Washington Post reports.
“The New York Republican, who has denied wrongdoing, received a barrage of negative headlines in April and May after the Daily Beast reported that he wrote legislation that would benefit a pharmaceutical company in which he held a substantial interest.”
Save to Favorites